Eli Lilly and Company LLY will report its fourth-quarter and full-year 2024 earnings on Feb. 6, before market open. The Zacks ...

That is none other than weight loss drug Zepbound ... other drugs in its portfolio such as Trulicity are being viewed as relics of a bygone era. Year over year, Trulicity sales dropped from ...

In December, Zepbound outperformed rival Novo Nordisk’s NVO Wegovy (semaglutide) in a weight-loss head-to-head study ... as seen in the chart below. The stupendous success of Mounjaro and ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

Winfrey opened up about her decision to use a medication to help her lose weight in an interview with People. Her new TV ...

In a recent episode of "The Oprah Podcast", she said that she took a GLP-1 agonist, which is a specific type of weight-loss medication. Some brand name GLP-1s include Ozempic and Trulicity ...

Eli Lilly investors and analysts said they want to hear details from the company on how exactly it plans to grow U.S. sales ...

Popular diabetes drugs such as Ozempic and Trulicity are among 25 drugs Medicare ... of its blockbuster diabetes drug Ozempic and weight loss drug Wegovy. The company's top executive was called ...

Some evidence suggests that the curcumin in turmeric may help promote weight loss. However, more research is necessary. Turmeric is a popular spice that people have used for a long time in cooking ...